Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History XAIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics XAIR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Beyond Air Inc

XAIR
Current price
3.26 USD -0.01 USD (-0.31%)
Last closed 3.24 USD
ISIN US08862L1035
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 15 032 758 USD
Yield for 12 month -71.29 %
1Y
3Y
5Y
10Y
15Y
XAIR
21.11.2021 - 28.11.2021

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York. Address: 900 Stewart Avenue, Garden City, NY, United States, 11530

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.25 USD

P/E Ratio

Dividend Yield

Financials XAIR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures XAIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+3 705 000 USD

Last Year

+1 159 000 USD

Current Quarter

+1 152 000 USD

Last Quarter

+1 072 000 USD

Current Year

-1 663 000 USD

Last Year

-1 307 000 USD

Current Quarter

-32 000 USD

Last Quarter

-215 000 USD
EBITDA -41 333 000 USD
Operating Margin TTM -622.74 %
Price to Earnings
Return On Assets TTM -63.97 %
PEG Ratio
Return On Equity TTM -233.48 %
Wall Street Target Price 2.25 USD
Revenue TTM 3 705 000 USD
Book Value 3.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 145.10 %
Dividend Yield
Gross Profit TTM -1 663 000 USD
Earnings per share -13.80 USD
Diluted Eps TTM -13.80 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation XAIR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 5.35
Price Sales TTM 4.06
Enterprise Value EBITDA -4.23
Price Book MRQ 1.11

Technical Indicators XAIR

For 52 Weeks

2.90 USD 13.52 USD
50 Day MA 3.80 USD
Shares Short Prior Month 3 444 361
200 Day MA 6.52 USD
Short Ratio 2.04
Shares Short 6 240 603
Short Percent 4.45 %